PT Nusa Raya Cipta Tbk (IDX:NRCA)

CTI BioPharma Revenue

PT Nusa Raya Cipta Tbk had revenue of 814.92B IDR in the quarter ending June 30, 2025, a decrease of -8.58%. This brings the company's revenue in the last twelve months to 3.47T, up 6.43% year-over-year. In the year 2024, PT Nusa Raya Cipta Tbk had annual revenue of 3.37T with 16.47% growth.

• Revenue (ttm): 3,470.52B
• Revenue Growth: +6.43%
• P/S Ratio: 0.70
• Revenue / Employee: 8.42B
• Employees: 413
• Market Cap: 2,432.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3,372.47B	476.96B	16.47%
Dec 31, 2023	2,895.51B	433.10B	17.59%
Dec 31, 2022	2,462.41B	792.69B	47.47%
Dec 31, 2021	1,669.71B	-416.03B	-19.95%
Dec 31, 2020	2,085.74B	-532.01B	-20.32%